Cumberland Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.84M | Sell |
32,060
-27,315
| -46% | -$6.36M | 0.59% | 37 |
|
|
2025
Q4 | $12.3M | Sell |
59,375
-8,440
| -12% | -$1.67M | 0.75% | 30 |
|
|
2025
Q3 | $12.6M | Buy |
67,815
+56,015
| +475% | +$9.6M | 0.82% | 29 |
|
|
2025
Q2 | $1.8M | Sell |
11,800
-2,730
| -19% | -$420K | 0.13% | 107 |
|
|
2025
Q1 | $2.41M | Sell |
14,530
-3,770
| -21% | -$590K | 0.19% | 90 |
|
|
2024
Q4 | $2.65M | Buy |
18,300
+2,850
| +18% | +$442K | 0.18% | 82 |
|
|
2024
Q3 | $2.5M | Buy |
15,450
+8,350
| +118% | +$1.33M | 0.17% | 83 |
|
|
2024
Q2 | $1.04M | Buy |
7,100
+2,168
| +44% | +$322K | 0.08% | 127 |
|
|
2024
Q1 | $780K | Buy |
+4,932
| New | +$785K | 0.06% | 144 |
|
|
2023
Q3 | – | Sell |
-8,679
| Closed | -$1.44M | – | 184 |
|
|
2023
Q2 | $1.44M | Sell |
8,679
-38
| -0.4% | -$6.13K | 0.13% | 104 |
|
|
2023
Q1 | $1.35M | Sell |
8,717
-30,006
| -77% | -$4.85M | 0.13% | 97 |
|
|
2022
Q4 | $6.84M | Sell |
38,723
-90,293
| -70% | -$15.6M | 0.72% | 30 |
|
|
2022
Q3 | $21.1M | Buy |
129,016
+650
| +0.5% | +$110K | 2.24% | 16 |
|
|
2022
Q2 | $22.8M | Buy |
128,366
+119,366
| +1,326% | +$21.3M | 2.17% | 17 |
|
|
2022
Q1 | $1.6M | Buy |
9,000
+1,357
| +18% | +$231K | 0.12% | 99 |
|
|
2021
Q4 | $1.31M | Sell |
7,643
-17,431
| -70% | -$2.85M | 0.09% | 118 |
|
|
2021
Q3 | $4.05M | Sell |
25,074
-10,493
| -30% | -$1.79M | 0.33% | 75 |
|
|
2021
Q2 | $5.86M | Buy |
35,567
+138
| +0.4% | +$22.8K | 0.46% | 59 |
|
|
2021
Q1 | $5.82M | Buy |
35,429
+10,634
| +43% | +$1.72M | 0.48% | 59 |
|
|
2020
Q4 | $3.9M | Sell |
24,795
-10,810
| -30% | -$1.6M | 0.35% | 71 |
|
|
2020
Q3 | $5.3M | Buy |
35,605
+7,170
| +25% | +$1.06M | 0.55% | 56 |
|
|
2020
Q2 | $4M | Sell |
28,435
-4,984
| -15% | -$726K | 0.41% | 63 |
|
|
2020
Q1 | $4.38M | Sell |
33,419
-14,104
| -30% | -$2M | 0.53% | 48 |
|
|
2019
Q4 | $6.93M | Sell |
47,523
-1,425
| -3% | -$193K | 0.62% | 50 |
|
|
2019
Q3 | $6.33M | Buy |
48,948
+88
| +0.2% | +$11.6K | 0.61% | 51 |
|
|
2019
Q2 | $6.8M | Sell |
48,860
-18,727
| -28% | -$2.59M | 0.65% | 46 |
|
|
2019
Q1 | $9.45M | Sell |
67,587
-80,526
| -54% | -$10.8M | 0.95% | 35 |
|
|
2018
Q4 | $19.1M | Sell |
148,113
-76,185
| -34% | -$10.6M | 2.16% | 17 |
|
|
2018
Q3 | $31M | Buy |
224,298
+189,245
| +540% | +$25.1M | 2.96% | 8 |
|
|
2018
Q2 | $4.25M | Buy |
+35,053
| New | +$4.37M | 0.43% | 53 |
|
Other funds holding JNJ
VCM
VPM
Cumberland Partners's JNJ Position: Q1 2026 in Review
Cumberland Partners reduced its Johnson & Johnson (JNJ) stake by 46% in Q1 2026, selling an estimated $6.36M and leaving 32,060 shares worth $7.84M. The position accounts for 0.59% of the portfolio, ranked #37.
Cumberland Partners first reported a position in JNJ in Q2 2018 and has held it in 30 quarters since. The position peaked at $31M in Q3 2018. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Cumberland Partners held 32,060 shares of Johnson & Johnson worth $7.84M as of Q1 2026.
- Cumberland Partners sold 27,315 Johnson & Johnson shares in Q1 2026, an estimated $6.36M.
- Johnson & Johnson made up 0.59% of Cumberland Partners's portfolio in Q1 2026, its #37 holding.
- Cumberland Partners first reported a position in Johnson & Johnson in Q2 2018 and has held it in 30 quarters since.
- Cumberland Partners's Johnson & Johnson position peaked at $31M in Q3 2018.
- 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Cumberland Partners's 13F filing for Q1 2026, filed 14 May 2026.